On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are In Silico Biosciences, Inc's own share of each project, not the project's full budget.
- Horizon 2020€1.1M · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- QSPainReliefPartner
Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach.
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€1.1Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Alma Mater Studiorum - Universita di BolognaItaly · 1 shared project
- Universiteit LeidenNetherlands · 1 shared project
- Universite Catholique de LouvainBelgium · 1 shared project
- Universidad Pompeu FabraSpain · 1 shared project
- Universitat Autonoma de BarcelonaSpain · 1 shared project
- Concentris Research Management GmbHGermany · 1 shared project
- Stichting Centre for Human Drug ResearchNetherlands · 1 shared project
- Cliniques Universitaires Saint-Luc ASBLBelgium · 1 shared project
- Pd-Value BVNetherlands · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- pharmacokinetics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.